The pharmaceutical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a potential development. Unlike injections, this approach offers a more convenient way to administer GLP-1 https://jakubzkha158378.bloginwi.com/74779560/glp-1-patches-a-new-approach-to-glucose-control